The controversial HPV vaccination made the headline several times in the past: Three years ago, Japanese scientists wanted to prove that it could supposedly trigger a severe neurological syndrome. At that time, her study was described as poor by many other scientists, some even demanded that it be withdrawn. In the meantime, the results of other studies have been published, which should prove the opposite. Now researchers in Scotland have also been able to determine the effect and security of such vaccines as part of an investigation. In Scotland, the girls have been vaccinated against HPV for more than 10 years and examined for cervical diseases over time.
For the study, the researchers had analyzed the patient file of more than 130,000 women. All women were examined for uterine diseases between the ages of 20 and 25. The results were clear: for women between 12 and 14 years against HPV, the cervical cancer risk was 90 % lower than in patients who were not vaccinated. In addition, the researchers could still find that the risk of women who were vaccinated at the age of 17 was significantly higher and therefore made the conclusion that vaccination between 12 and 14 years offers effective protection against cervical cancer.
The virus is transmitted almost exclusively by sexual contacts. HPV pathogens manage in the skin and mucous membrane in injuriesthe human body. Most HPV infections heal from themselves, over time, but types 16 and 18 are particularly dangerous and can cause the development of cervical cancer. Therefore, the constant vaccination commission in Germany recommends vaccination in both girls and boys between the ages of nine and fourteen.
